Metabolic Disorders Panel

Metabolic Disorders Panel analyzes Genes associated with metabolic conditions present in national and international newborn screening (NBS) programs. This panel may be appropriate for symptomatic infants, premature infants, or babies in the neonatal intensive care unit where confounding factors, such as liver immaturity or total parenteral nutrition, cause an increased chance of ambiguous screening results on traditional, biochemical-based testing. Given the clinical overlap between these conditions, comprehensive testing enables a more efficient evaluation of multiple conditions based on a single indication for testing.

Genetic testing of these Genes may confirm a suspected diagnosis and help guide treatment and management decisions.